Trickle Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (383)	1/18/2001 4:11:54 AM
From: nigel bates	of 1784

MIL ...Biosciences had a 7 percent growth rate in local currency in the fourth quarter, following a 9 percent, 10 percent, and 14 percent growth rate in the first, second and third quarters, respectively, yielding a 10 percent growth rate for all of 2000 compared to 8 percent for 1999. Biosciences is an accelerating growth business, particularly with our new directions in genomics, proteomics, drug discovery and biotherapeutic manufacturing. We are very excited about our recent announcements of new alliances and new products that expand our market presence in these growing areas.'' Revenues by Business Segment for the Year %Growth Local 1999 2000 % Growth Currency Biosciences (1) $564 $599 6% 10% Microelectronics (2) 207 355 71% 70% Total $771 $954 24% 26% ... Revenues by Business Segment for the Fourth Quarter % Growth Local Q4 1999 Q4 2000 % Growth Currency Biosciences (1) $150 $150 0% 7% Microelectronics (2) 65 101 55% 60%

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next